K
Kriya Therapeutics
Innovative gene therapies targeting prevalent chronic diseases
At a glance
- Founded
- 2019
- Headquarters
- Morrisville, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Latest news
Press, funding announcements and product moves mentioning Kriya Therapeutics.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A8 investors entered at this stage
- AAAsia Alpha
Foresite Capital- AMAmplo
- DPDexcel Pharma
- PMPaul Manning
- NCNarya Capital
- QLQVT Financial LP
- BVBluebird Ventures
Series B and later10 investors entered at this stage
- WPWoodline Partners
- LCLightswitch Capital
Premji Invest- CCCAM Capital
- PCPatient Square Capital
- JFJDRF T1D Fund
- TCThiel Capital
- TCTranshuman Capital
Alumni Ventures- HOHongkou
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
11 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Kriya Therapeutics was the backer or acquirer, 2022–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Kriya Therapeutics's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Where Kriya Therapeutics deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
Kriya Therapeutics's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Kriya Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Kriya Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.